Research on the underlying causes of idiopathic scoliosis has become a major focus in the last few years. Although conventional wisdom has always been that scoliosis is a random spinal deformity with no known cause, several researchers have discovered specific hormonal, genetic, and neurotransmitter abnormalities in patients with this life-altering disorder. Scoliosis is really now more understood as but one orthopedic symptom of a general systemic disease that requires a multi-factorial treatment strategy.
In my ongoing efforts to push this rock forward, I was informed that a commentary I wrote on neurotransmitters and scoliosis was accepted for publication in Current Pediatric Research, an open access peer-reviewed journal. The main purpose of this article is to discuss the main neurotransmitters believed to be involved in scoliosis etiology or progression, and identify potential treatment options for neurotransmitter imbalances.
Although the article was written for a pediatric journal, the information nonetheless applies to adult scoliosis patients who have had their scoliosis since childhood. These same neurotransmitter imbalances are popping up in adult scoliosis patients as well, and it’s imperative to re-balance these neurotransmitter ratios in order to give exercise-based scoliosis therapies the best chance of working.
I am honored that this article was accepted. It is already the third paper I have had accepted for peer-reviewed publication this year on scoliosis treatment.
Onward and upward!
